News and Press Releases
Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation
Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming phase 2b study following successful phase 1b/2a study 12 March 2024 -- Cambridgeshire and Belfast, UK --...
Category: Clinical Trials
Posted: March 12, 2024
EmpowerPharm Awaits Phase 2 Clinical Trial on Ground-Breaking Treatment to Manage Social Anxiety Disorder
First Cannabidiol treatment study of its kind to be approved by the FDA 11 March 2024 -- Ontario, Canada -- EmpowerPharm is delighted to announce that the final participant has completed...
Category: Clinical Trials, Pharmaceutical
Posted: March 11, 2024
Education and tailored communications are required to bridge the ethnicity gap in clinical trial participation
6 in 10 (58%) adults in the UK reported that they would be willing to participate in a clinical trial. However, ethnic minority adults were significantly less likely to participate,...
Category: Clinical Trials
Posted: March 11, 2024
Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics
Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics 11 March 2024 -- Dundee, UK --...
Category: Drug Discovery
Posted: March 11, 2024
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK
Supply chain technology provider Finboot announces latest funding round
Funding to accelerate Finboot’s platform, MARCO in the net-zero transition Strategic investor together with Wealth Club played key role in bringing in specialist investors into the latest round. 11 March...
Category: Biotechnology, Logistics
Posted: March 11, 2024
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalised Pustular Psoriasis
8 March 2024 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CorEvitas syndicated clinical registry in generalised pustular...
Category: Other, Pharmaceutical
Posted: March 8, 2024
Johnson & Johnson submits application to the European Medicines Agency for DARZALEX (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma
Submission supported by data from phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk of progression or death, compared to standard of care regimen...
Category: BioManufacturing, Drug Discovery
Posted: March 6, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Signant Health Unveils Next-Level Advancements in Efficient, Compliant IP Management with Updates to its Clinical Supply Solutions
6 March 2024 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the release of key enhancements to its clinical supply management...
Category: Clinical Trials
Posted: March 6, 2024
ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team
6 March 2024 -- London, UK -- A global, interdisciplinary team of researchers has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle...
Category: Clinical Trials, Pharmaceutical
Posted: March 6, 2024
Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings
Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring. Coriolis is now preparing for inspection by the competent surveillance authority for...
Category: Manufacturing and Packing
Posted: March 6, 2024
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience 6 March 2024 – Laupheim, Germany; Milford, MA, US; and Stevenage,...
Category: BioManufacturing, Drug Discovery
Posted: March 6, 2024
CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award
2024 Annual Association of Clinical Data Management (ACDM24) recognises CluePoints’ improved methodology to proactively identify and address data quality. 5 March 2024 -- Pennsylvania, US -- CluePoints, providers of best-in-class statistical...
Category: Clinical Trials
Posted: March 5, 2024
Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes
5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...
Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer
First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in phase 1b study in platinum-resistant ovarian cancer (PROC) patients scheduled...
Category: BioManufacturing
Posted: March 5, 2024
Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by US Food and Drug Administration
Compound is currently undergoing clinical trials as a potential treatment option for patients with RET altered tumours 5 March 2024 -- London, UK -- Ellipses Pharma, a global drug development...
Category: Drug Discovery
Posted: March 5, 2024
